Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifabutin + amoxicillin + vonoprazan 7-day regimen as third- or later-line H. pylori eradication
jRCTs031180362Completed
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vonoprazan, amoxicillin and rifabutin in Helicobacter pylori infection. Primary endpoint: H. pylori eradication efficacy. Started Mar 2016; status: completed.
02
Drugs
vonoprazanamoxicillinrifabutin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on jRCTs031180362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180362.